Page last updated: 2024-09-04

tariquidar and salvinorin a

tariquidar has been researched along with salvinorin a in 1 studies

Compound Research Comparison

Studies (tariquidar)	Trials (tariquidar)	Recent Studies (post-2010) (tariquidar)	Studies (salvinorin a)	Trials (salvinorin a)	Recent Studies (post-2010) (salvinorin a)
210	16	138	247	7	128

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butelman, ER; Caspers, M; Kreek, MJ; Lovell, KM; Prisinzano, TE	1

Other Studies

1 other study(ies) available for tariquidar and salvinorin a

Article	Year
Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Blepharoptosis; Blood-Brain Barrier; Central Nervous System; Discrimination, Psychological; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Facial Muscles; Female; Hallucinogens; Loperamide; Macaca mulatta; Male; Quinolines; Receptors, Opioid, kappa; Salvia	2012

Article

Year

Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo.

The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:3

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Blepharoptosis; Blood-Brain Barrier; Central Nervous System; Discrimination, Psychological; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Facial Muscles; Female; Hallucinogens; Loperamide; Macaca mulatta; Male; Quinolines; Receptors, Opioid, kappa; Salvia

2012